Ipamorelin, the first selective growth hormone secretagogue
Raun K, Hansen BS, Johansen NL, et al. (1998). European Journal of Endocrinology.
Summary
The original characterisation of ipamorelin by its developers. In cell and animal models it prompted growth hormone release with little measured effect on cortisol or prolactin, which the authors contrasted with earlier secretagogues. A pharmacology paper from the company that developed the compound.